Nutritional and Metabolic Management of Toxidermia Patients Requiring Intensive Care (TEN Metabolism)
NCT05320653 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 35
Last updated 2022-08-05
Summary
Retrospective observational cohort study including all patients admitted for toxidermia (Lyell syndrome, Stevens-Johnson Syndrome (SJS), or other extensive skin destruction) to the Burn unit of the adult ICU of the Lausanne burn center between 2006 and 2020.
Inclusion criteria: age \>18 years and admission to the burn-ICU for toxidermia whatever body surface affected.
Exclusion criteria: to have declined access to the medical record, a stay shorter than 24 hours, and major burns. The observation period will be limited to the first 31 days of the ICU stay.
All variables related to nutritional and metabolic management will be recorded
Conditions
- Stevens-Johnson Syndrome Toxic Epidermal Necrolysis Spectrum
Interventions
- DIETARY_SUPPLEMENT
-
Medical nutrition
Nutrition therapy of the critically ill patients
Sponsors & Collaborators
-
Centre Hospitalier Universitaire Vaudois
lead OTHER
Principal Investigators
-
Eckert Philippe, MD · Université de Lausanne, Director of the ICU
Eligibility
- Min Age
- 16 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2006-01-01
- Primary Completion
- 2020-12-31
- Completion
- 2022-05-31
More Related Trials
-
Dermatological Evaluation of Topical Compatibility, Primary Skin Irritability, Accumulated Skin Irritability, and Dermal Sensitisation
NCT02419248 ·Status: COMPLETED
-
Impact of Exposure to Cosmetics on Sensitive Skin
NCT03958968 ·Status: COMPLETED
-
Histopathological Comparison Between Superficial Pressure Ulcers and Incontinence-associated Dermatitis
NCT03685929 ·Status: COMPLETED
-
Severe Cutaneous Adverse Reactions in Thailand
NCT02574988 ·Status: UNKNOWN
-
A Study Assessing the Impact of Dermatology Consultation in Patients Presenting With Possible Cellulitis
NCT01795092 ·Status: COMPLETED ·Phase: NA
-
Characterization of Visual Characteristics in Allergic Contact Dermatitis Using the Skincam® Tool
NCT06351449 ·Status: NOT_YET_RECRUITING
-
Safety Study of Gene-modified Autologous Fibroblasts in Recessive Dystrophic Epidermolysis Bullosa
NCT02493816 ·Status: COMPLETED ·Phase: PHASE1
-
Clinical Evaluation of the Phototoxic Potential of Xenaderm Ointment
NCT00644917 ·Status: COMPLETED ·Phase: PHASE1
-
Using a Contact Dermatitis Model With Biologic Medications to Study Skin Inflammation
NCT05535738 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2/PHASE3
-
Effect of Tetrix on Alleviation of Burning,Itching Associated With Lesions of Contact Dermatitis
NCT00646867 ·Status: COMPLETED ·Phase: NA
-
Skin Pathology Assessment With Optical Technologies
NCT04295824 ·Status: COMPLETED
-
Determination of Sensitive Skin and Its Biophysical Response in a Latin-American Population
NCT01591993 ·Status: COMPLETED ·Phase: PHASE4
-
Study of Skin and Gut Microbiome in a Skin Condition Involving Skin Barrier Impairment and Allergic Symptoms: Netherton Syndrome
NCT07280091 ·Status: NOT_YET_RECRUITING
-
An Evaluation of the Reduction in Erythema in Adult Patients With Moderate to Severe Persistent Facial Erythema Associated With Rosacea
NCT03352323 ·Status: COMPLETED ·Phase: PHASE3
-
Enhancing SKIN Health and Safety in Aged CARE
NCT03824886 ·Status: COMPLETED ·Phase: NA
-
Risk Factors for Incontinence-Associated Dermatitis (IAD) in ICU Patients Suffering From Fecal Incontinence
NCT02996357 ·Status: COMPLETED
-
Impact of COVID-19 on Occupational Dermato-allergology Consultations of Health Peronnel
NCT06237010 ·Status: COMPLETED
-
Evaluation of Tetrix Cream as a Protective Barrier Against Injurious Materials
NCT00643630 ·Status: COMPLETED ·Phase: NA
-
Skin Barrier Biophysical Properties and Clinical Appearance After Moisturizer in Dry Skin
NCT03093597 ·Status: COMPLETED ·Phase: NA
-
Dermatological Assessment of Photoallergy and Phototoxicity
NCT04250623 ·Status: COMPLETED ·Phase: NA
-
Dermatological Assessment of Primary Dermal Irritability Accumulated, Sensitization, Photoallergy and Phototoxicity.
NCT04332445 ·Status: COMPLETED ·Phase: NA
-
Novel Skin Care for Immunotherapy- Related Dermatologic Toxicities
NCT04929834 ·Status: UNKNOWN ·Phase: NA
-
Soothing and Re-epithelizing Activity of New Cosmetic Formulations in Comparison to Placebo and Untreated Control Area
NCT03464890 ·Status: COMPLETED ·Phase: NA
-
The Use of Oral Steroids in the Treatment of Cellulitis
NCT00893048 ·Status: WITHDRAWN ·Phase: PHASE2
-
Methotrexat to Hand Eczema in the BIOSKIN Cohort
NCT07338305 ·Status: ACTIVE_NOT_RECRUITING